阻滞剂-话题@MedSci

#阻滞剂#

205篇内容 | 4063人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2085826, encodeId=8b892085826ba, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=川崎病患儿的TNF-α阻滞剂干预与安慰剂或其他治疗的比较, objectType=article, longId=178779, objectId=26051e8779d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26051e8779d5, replyNumber=0, likeNumber=68, createdTime=2020-03-31, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26051e8779d5, moduleTitle=川崎病患儿的TNF-α阻滞剂干预与安慰剂或其他治疗的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26051e8779d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085822, encodeId=9966208582229, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=JACC：ACEI和β受体阻滞剂能减少化疗乳腺癌患者的心脏毒性, objectType=article, longId=168960, objectId=a861168960b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a861168960b7, replyNumber=0, likeNumber=0, createdTime=2020-05-30, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a861168960b7, moduleTitle=JACC：ACEI和β受体阻滞剂能减少化疗乳腺癌患者的心脏毒性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a861168960b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085809, encodeId=003f2085809a5, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=Am J Cardiol：心衰患者用>25 mg/d的β受体阻滞剂降低死亡率, objectType=article, longId=151198, objectId=77581511982e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77581511982e, replyNumber=0, likeNumber=94, createdTime=2019-04-25, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77581511982e, moduleTitle=Am J Cardiol：心衰患者用>25 mg/d的β受体阻滞剂降低死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77581511982e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085819, encodeId=5616208581940, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=JACC：钙离子通道阻滞剂可改善桡动脉冠脉搭桥患者预后, objectType=article, longId=166280, objectId=5e09166280dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e09166280dd, replyNumber=0, likeNumber=0, createdTime=2019-12-07, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e09166280dd, moduleTitle=JACC：钙离子通道阻滞剂可改善桡动脉冠脉搭桥患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e09166280dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085805, encodeId=28ee20858052d, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=JAHA：急性心梗伴肝硬化患者的β受体阻滞剂该如何选择？, objectType=article, longId=150169, objectId=8923150169bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8923150169bb, replyNumber=0, likeNumber=71, createdTime=2018-10-09, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8923150169bb, moduleTitle=JAHA：急性心梗伴肝硬化患者的β受体阻滞剂该如何选择？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8923150169bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085812, encodeId=f6b4208581273, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=Clin Res Cardiol：β受体阻滞剂与慢性心力衰竭——达到“目标剂量”还是“目标心率”？, objectType=article, longId=154613, objectId=fd541546136d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd541546136d, replyNumber=0, likeNumber=81, createdTime=2019-07-09, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd541546136d, moduleTitle=Clin Res Cardiol：β受体阻滞剂与慢性心力衰竭——达到“目标剂量”还是“目标心率”？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd541546136d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085807, encodeId=0f9c208580e15, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=Brit J Surg：β受体阻滞剂治疗对急诊结肠癌术后早期死亡率的影响, objectType=article, longId=150404, objectId=af2015040478, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af2015040478, replyNumber=0, likeNumber=92, createdTime=2019-04-06, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af2015040478, moduleTitle=Brit J Surg：β受体阻滞剂治疗对急诊结肠癌术后早期死亡率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af2015040478)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085806, encodeId=84c9208580634, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=J Periodontal Res：三种钙通道阻滞剂对牙龈增生的影响, objectType=article, longId=150239, objectId=80e8150239e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80e8150239e1, replyNumber=0, likeNumber=55, createdTime=2019-04-17, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80e8150239e1, moduleTitle=J Periodontal Res：三种钙通道阻滞剂对牙龈增生的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80e8150239e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085801, encodeId=a3e1208580146, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=Lancet：高血压患者接受钙通道阻滞剂和他汀类药物可降低患者长期心血管死亡风险, objectType=article, longId=147519, objectId=000214e519c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=000214e519c4, replyNumber=0, likeNumber=61, createdTime=2019-04-19, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=000214e519c4, moduleTitle=Lancet：高血压患者接受钙通道阻滞剂和他汀类药物可降低患者长期心血管死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=000214e519c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085798, encodeId=057a2085e9839, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=循证证据夯实地位：高选择性β1受体阻滞剂心血管获益更佳, objectType=article, longId=144355, objectId=6914144355ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6914144355ff, replyNumber=0, likeNumber=68, createdTime=2019-05-16, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6914144355ff, moduleTitle=循证证据夯实地位：高选择性β1受体阻滞剂心血管获益更佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6914144355ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085817, encodeId=20c1208581ece, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=Lancet：代偿性肝硬化伴门脉高压症患者使用β阻滞剂可改善预后, objectType=article, longId=164757, objectId=7be1164e5777, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7be1164e5777, replyNumber=0, likeNumber=56, createdTime=2019-04-30, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7be1164e5777, moduleTitle=Lancet：代偿性肝硬化伴门脉高压症患者使用β阻滞剂可改善预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7be1164e5777)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085803, encodeId=1ca8208580327, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=JAHA：肝硬化合并急性心肌梗死患者β受体阻滞剂的选择, objectType=article, longId=149357, objectId=2f0e14935ebb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f0e14935ebb, replyNumber=0, likeNumber=78, createdTime=2018-10-05, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f0e14935ebb, moduleTitle=JAHA：肝硬化合并急性心肌梗死患者β受体阻滞剂的选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f0e14935ebb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085810, encodeId=770720858107f, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=J Aller Cl Imm-Pract：过敏反应与服用β受体阻滞剂和血管紧张素转换酶抑制剂的关系, objectType=article, longId=152882, objectId=97e515288294, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97e515288294, replyNumber=0, likeNumber=73, createdTime=2018-12-19, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97e515288294, moduleTitle=J Aller Cl Imm-Pract：过敏反应与服用β受体阻滞剂和血管紧张素转换酶抑制剂的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97e515288294)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085799, encodeId=32d62085e99b8, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=2018 临床实践指南：α受体阻滞剂治疗单纯性输尿管结石, objectType=article, longId=144578, objectId=630e1445e89b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=630e1445e89b, replyNumber=0, likeNumber=25, createdTime=2019-03-01, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=630e1445e89b, moduleTitle=2018 临床实践指南：α受体阻滞剂治疗单纯性输尿管结石, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=630e1445e89b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085796, encodeId=e9f92085e96ff, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=Pharmacotherapy：MI后再灌注标准治疗β受体阻滞剂受质疑！, objectType=article, longId=141676, objectId=ab751416e6bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab751416e6bd, replyNumber=0, likeNumber=84, createdTime=2018-10-08, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab751416e6bd, moduleTitle=Pharmacotherapy：MI后再灌注标准治疗β受体阻滞剂受质疑！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab751416e6bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085785, encodeId=e9922085e8546, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=Nephrol Dial Transpl：糖尿病合并慢性肾病 RAAS阻滞剂在治疗上有优越性吗？, objectType=article, longId=131185, objectId=2e94131185d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e94131185d7, replyNumber=0, likeNumber=68, createdTime=2018-03-06, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e94131185d7, moduleTitle=Nephrol Dial Transpl：糖尿病合并慢性肾病 RAAS阻滞剂在治疗上有优越性吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e94131185d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085811, encodeId=8225208581182, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=Circulation：ACS合并CKD：P2Y12-ADP受体阻滞剂疗效如何？, objectType=article, longId=153171, objectId=ed171531e1f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed171531e1f1, replyNumber=0, likeNumber=0, createdTime=2019-04-20, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed171531e1f1, moduleTitle=Circulation：ACS合并CKD：P2Y12-ADP受体阻滞剂疗效如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed171531e1f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085814, encodeId=a6b3208581454, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=Eur Heart J：β受体阻滞剂、钙拮抗剂与稳定性冠状动脉疾病患者死亡率的关系, objectType=article, longId=157152, objectId=5a6115e152ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a6115e152ee, replyNumber=0, likeNumber=80, createdTime=2019-04-11, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a6115e152ee, moduleTitle=Eur Heart J：β受体阻滞剂、钙拮抗剂与稳定性冠状动脉疾病患者死亡率的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a6115e152ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085791, encodeId=20812085e91b5, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=糖尿病患者：我能不能用β受体阻滞剂？, objectType=article, longId=133855, objectId=52b31338551a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52b31338551a, replyNumber=0, likeNumber=102, createdTime=2018-09-08, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52b31338551a, moduleTitle=糖尿病患者：我能不能用β受体阻滞剂？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52b31338551a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085792, encodeId=0f7b2085e92a5, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=Mayo Clin Proc：β受体阻滞剂增加冠心病糖尿病患者死亡风险, objectType=article, longId=135004, objectId=878013500472, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=878013500472, replyNumber=0, likeNumber=72, createdTime=2018-11-12, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=878013500472, moduleTitle=Mayo Clin Proc：β受体阻滞剂增加冠心病糖尿病患者死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=878013500472)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

阻滞剂

2020-05-29

一叶知秋 (审核中...)

前往app查看评论内容

#阻滞剂#

川崎病患儿的TNF-α阻滞剂干预与安慰剂或其他治疗的比较

2020-03-31

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

JACC：ACEI和β受体阻滞剂能减少化疗乳腺癌患者的心脏毒性

2020-05-30

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

Am J Cardiol：心衰患者用>25 mg/d的β受体阻滞剂降低死亡率

2019-04-25

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

JACC：钙离子通道阻滞剂可改善桡动脉冠脉搭桥患者预后

2019-12-07

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

JAHA：急性心梗伴肝硬化患者的β受体阻滞剂该如何选择？

2018-10-09

仁心济世 (审核中...)

前往app查看评论内容

#阻滞剂#

Clin Res Cardiol：β受体阻滞剂与慢性心力衰竭——达到“目标剂量”还是“目标心率”？

2019-07-09

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

Brit J Surg：β受体阻滞剂治疗对急诊结肠癌术后早期死亡率的影响

2019-04-06

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

J Periodontal Res：三种钙通道阻滞剂对牙龈增生的影响

2019-04-17

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

Lancet：高血压患者接受钙通道阻滞剂和他汀类药物可降低患者长期心血管死亡风险

2019-04-19

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

循证证据夯实地位：高选择性β1受体阻滞剂心血管获益更佳

2019-05-16

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

Lancet：代偿性肝硬化伴门脉高压症患者使用β阻滞剂可改善预后

2019-04-30

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

JAHA：肝硬化合并急性心肌梗死患者β受体阻滞剂的选择

2018-10-05

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

J Aller Cl Imm-Pract：过敏反应与服用β受体阻滞剂和血管紧张素转换酶抑制剂的关系

2018-12-19

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

2018 临床实践指南：α受体阻滞剂治疗单纯性输尿管结石

2019-03-01

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

Pharmacotherapy：MI后再灌注标准治疗β受体阻滞剂受质疑！

2018-10-08

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

Nephrol Dial Transpl：糖尿病合并慢性肾病 RAAS阻滞剂在治疗上有优越性吗？

2018-03-06

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

Circulation：ACS合并CKD：P2Y12-ADP受体阻滞剂疗效如何？

2019-04-20

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

Eur Heart J：β受体阻滞剂、钙拮抗剂与稳定性冠状动脉疾病患者死亡率的关系

2019-04-11

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

糖尿病患者：我能不能用β受体阻滞剂？

2018-09-08

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

Mayo Clin Proc：β受体阻滞剂增加冠心病糖尿病患者死亡风险

2018-11-12

科室
- - 订阅+
  - 更多科室
工具
服务